Prevalence of symptoms experienced by patients with different clinical types of psoriasis

F. Sampogna, P. Gisondi, C. F. Melchi, P. Amerio, G. Girolomoni, Damiano Abeni

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

Background: The main dermatology textbooks describe only in passing pruritus in psoriasis and rarely mention other symptoms. A quantification of the presence of symptoms is not available for clinical subgroups of psoriasis. Objectives: To investigate the prevalence of symptoms experienced by patients with different clinical types of psoriasis. Methods: The study was carried out in patients hospitalized for psoriasis between February 2000 and February 2002 at the inpatient wards of the Istituto Dermopatico dell'Immacolata, Rome, Italy. Symptoms were evaluated using the symptoms scale of Skindex-29. Clinical severity was assessed by the dermatologists using the Psoriasis Area and Severity Index (PASI), and by the patients completing the self-administered PASI. Psychiatric morbidity was evaluated using the 12-item General Health Questionnaire. Results: In total, 936 eligible patients were analysed. The proportions of patients experiencing symptoms often or always in the 4 weeks before hospitalization were: 63.8% itching, 59.7% irritation, 46.1% burning/stinging, 39% sensitivity, 26% pain (from 10% in guttate psoriasis to 50% in arthropathic), 25.4% bleeding (17% pustular, 19% localized plaque, 36% palmoplantar), and 23.9% bothered by water (from 8.5% in the guttate form to 68% in palmoplantar). The prevalence of all symptoms was significantly higher in women and tended to increase with clinical severity. Conclusions: Our study provides evidence of the high frequency of a number of symptoms in different subgroups of psoriasis patients determined by their sociodemographic characteristics, clinical type and disease severity. Symptoms represent a serious disabling factor in patients affected by psoriasis, including those with low levels of psychological distress. Dermatologists should include symptoms in the evaluation of disease severity both in clinical practice and in clinical trials.

Original languageEnglish
Pages (from-to)594-599
Number of pages6
JournalBritish Journal of Dermatology
Volume151
Issue number3
DOIs
Publication statusPublished - Sep 2004

Fingerprint

Psoriasis
Pruritus
Symptom Assessment
Textbooks
Dermatology
Italy
Psychiatry
Inpatients
Hospitalization
Clinical Trials
Hemorrhage
Psychology
Morbidity
Pain
Water
Health

Keywords

  • Itching
  • PASI
  • Psoriasis
  • Quality of life
  • Skindex-29
  • Symptoms

ASJC Scopus subject areas

  • Dermatology

Cite this

Prevalence of symptoms experienced by patients with different clinical types of psoriasis. / Sampogna, F.; Gisondi, P.; Melchi, C. F.; Amerio, P.; Girolomoni, G.; Abeni, Damiano.

In: British Journal of Dermatology, Vol. 151, No. 3, 09.2004, p. 594-599.

Research output: Contribution to journalArticle

Sampogna, F. ; Gisondi, P. ; Melchi, C. F. ; Amerio, P. ; Girolomoni, G. ; Abeni, Damiano. / Prevalence of symptoms experienced by patients with different clinical types of psoriasis. In: British Journal of Dermatology. 2004 ; Vol. 151, No. 3. pp. 594-599.
@article{4894cb38dd114d41a7df604f7f1ca782,
title = "Prevalence of symptoms experienced by patients with different clinical types of psoriasis",
abstract = "Background: The main dermatology textbooks describe only in passing pruritus in psoriasis and rarely mention other symptoms. A quantification of the presence of symptoms is not available for clinical subgroups of psoriasis. Objectives: To investigate the prevalence of symptoms experienced by patients with different clinical types of psoriasis. Methods: The study was carried out in patients hospitalized for psoriasis between February 2000 and February 2002 at the inpatient wards of the Istituto Dermopatico dell'Immacolata, Rome, Italy. Symptoms were evaluated using the symptoms scale of Skindex-29. Clinical severity was assessed by the dermatologists using the Psoriasis Area and Severity Index (PASI), and by the patients completing the self-administered PASI. Psychiatric morbidity was evaluated using the 12-item General Health Questionnaire. Results: In total, 936 eligible patients were analysed. The proportions of patients experiencing symptoms often or always in the 4 weeks before hospitalization were: 63.8{\%} itching, 59.7{\%} irritation, 46.1{\%} burning/stinging, 39{\%} sensitivity, 26{\%} pain (from 10{\%} in guttate psoriasis to 50{\%} in arthropathic), 25.4{\%} bleeding (17{\%} pustular, 19{\%} localized plaque, 36{\%} palmoplantar), and 23.9{\%} bothered by water (from 8.5{\%} in the guttate form to 68{\%} in palmoplantar). The prevalence of all symptoms was significantly higher in women and tended to increase with clinical severity. Conclusions: Our study provides evidence of the high frequency of a number of symptoms in different subgroups of psoriasis patients determined by their sociodemographic characteristics, clinical type and disease severity. Symptoms represent a serious disabling factor in patients affected by psoriasis, including those with low levels of psychological distress. Dermatologists should include symptoms in the evaluation of disease severity both in clinical practice and in clinical trials.",
keywords = "Itching, PASI, Psoriasis, Quality of life, Skindex-29, Symptoms",
author = "F. Sampogna and P. Gisondi and Melchi, {C. F.} and P. Amerio and G. Girolomoni and Damiano Abeni",
year = "2004",
month = "9",
doi = "10.1111/j.1365-2133.2004.06093.x",
language = "English",
volume = "151",
pages = "594--599",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Blackwell Publishing Ltd",
number = "3",

}

TY - JOUR

T1 - Prevalence of symptoms experienced by patients with different clinical types of psoriasis

AU - Sampogna, F.

AU - Gisondi, P.

AU - Melchi, C. F.

AU - Amerio, P.

AU - Girolomoni, G.

AU - Abeni, Damiano

PY - 2004/9

Y1 - 2004/9

N2 - Background: The main dermatology textbooks describe only in passing pruritus in psoriasis and rarely mention other symptoms. A quantification of the presence of symptoms is not available for clinical subgroups of psoriasis. Objectives: To investigate the prevalence of symptoms experienced by patients with different clinical types of psoriasis. Methods: The study was carried out in patients hospitalized for psoriasis between February 2000 and February 2002 at the inpatient wards of the Istituto Dermopatico dell'Immacolata, Rome, Italy. Symptoms were evaluated using the symptoms scale of Skindex-29. Clinical severity was assessed by the dermatologists using the Psoriasis Area and Severity Index (PASI), and by the patients completing the self-administered PASI. Psychiatric morbidity was evaluated using the 12-item General Health Questionnaire. Results: In total, 936 eligible patients were analysed. The proportions of patients experiencing symptoms often or always in the 4 weeks before hospitalization were: 63.8% itching, 59.7% irritation, 46.1% burning/stinging, 39% sensitivity, 26% pain (from 10% in guttate psoriasis to 50% in arthropathic), 25.4% bleeding (17% pustular, 19% localized plaque, 36% palmoplantar), and 23.9% bothered by water (from 8.5% in the guttate form to 68% in palmoplantar). The prevalence of all symptoms was significantly higher in women and tended to increase with clinical severity. Conclusions: Our study provides evidence of the high frequency of a number of symptoms in different subgroups of psoriasis patients determined by their sociodemographic characteristics, clinical type and disease severity. Symptoms represent a serious disabling factor in patients affected by psoriasis, including those with low levels of psychological distress. Dermatologists should include symptoms in the evaluation of disease severity both in clinical practice and in clinical trials.

AB - Background: The main dermatology textbooks describe only in passing pruritus in psoriasis and rarely mention other symptoms. A quantification of the presence of symptoms is not available for clinical subgroups of psoriasis. Objectives: To investigate the prevalence of symptoms experienced by patients with different clinical types of psoriasis. Methods: The study was carried out in patients hospitalized for psoriasis between February 2000 and February 2002 at the inpatient wards of the Istituto Dermopatico dell'Immacolata, Rome, Italy. Symptoms were evaluated using the symptoms scale of Skindex-29. Clinical severity was assessed by the dermatologists using the Psoriasis Area and Severity Index (PASI), and by the patients completing the self-administered PASI. Psychiatric morbidity was evaluated using the 12-item General Health Questionnaire. Results: In total, 936 eligible patients were analysed. The proportions of patients experiencing symptoms often or always in the 4 weeks before hospitalization were: 63.8% itching, 59.7% irritation, 46.1% burning/stinging, 39% sensitivity, 26% pain (from 10% in guttate psoriasis to 50% in arthropathic), 25.4% bleeding (17% pustular, 19% localized plaque, 36% palmoplantar), and 23.9% bothered by water (from 8.5% in the guttate form to 68% in palmoplantar). The prevalence of all symptoms was significantly higher in women and tended to increase with clinical severity. Conclusions: Our study provides evidence of the high frequency of a number of symptoms in different subgroups of psoriasis patients determined by their sociodemographic characteristics, clinical type and disease severity. Symptoms represent a serious disabling factor in patients affected by psoriasis, including those with low levels of psychological distress. Dermatologists should include symptoms in the evaluation of disease severity both in clinical practice and in clinical trials.

KW - Itching

KW - PASI

KW - Psoriasis

KW - Quality of life

KW - Skindex-29

KW - Symptoms

UR - http://www.scopus.com/inward/record.url?scp=4944231501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4944231501&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2133.2004.06093.x

DO - 10.1111/j.1365-2133.2004.06093.x

M3 - Article

C2 - 15377345

AN - SCOPUS:4944231501

VL - 151

SP - 594

EP - 599

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 3

ER -